Search alternatives:
large increased » large increases (Expand Search), larger increases (Expand Search), age increased (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
b larger » _ larger (Expand Search), _ large (Expand Search), a large (Expand Search)
ai large » a large (Expand Search), via large (Expand Search), _ large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
Showing 161 - 180 results of 13,548 for search '(((( b large decrease ) OR ( ((b larger) OR (i large)) decrease ))) OR ( ai large increased ))', query time: 0.84s Refine Results
  1. 161
    The rate the bias decreases with sample duration is higher for cells with higher activity levels.

    The rate the bias decreases with sample duration is higher for cells with higher activity levels. by Liron Sheintuch (12078310)

    Published 2022
    Save to List
    Saved in:
  2. 162
    Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx

    Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx by Dewan Zhao (21547445)

    Published 2025
    “…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”
    Save to List
    Saved in:
  3. 163
    Z-stack showing <i>N</i>. <i>bombycis</i> infection in the nurse cells and oocytes at the vitellogenesis stage on the fifth day of pupation.

    Z-stack showing <i>N</i>. <i>bombycis</i> infection in the nurse cells and oocytes at the vitellogenesis stage on the fifth day of pupation. by Chunxia Wang (766713)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 164
    Z-stack showing <i>N</i>. <i>bombycis</i> adhering to the surface of the ovariole aat the previtellogenesis stage on the fifth day of pupation.

    Z-stack showing <i>N</i>. <i>bombycis</i> adhering to the surface of the ovariole aat the previtellogenesis stage on the fifth day of pupation. by Chunxia Wang (766713)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 165
    Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  6. 166
    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  7. 167
    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  8. 168
    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  9. 169
    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  10. 170
    Results of SD-TOPSIS application ‐ combinations B1-B5.

    Results of SD-TOPSIS application ‐ combinations B1-B5. by Roman Vavrek (13200141)

    Published 2024
    Save to List
    Saved in:
  11. 171
    <b>Normative values for maximal voluntary isometric contraction of the plantarflexors: A large observational cross-sectional study</b>

    <b>Normative values for maximal voluntary isometric contraction of the plantarflexors: A large observational cross-sectional study</b> by Samuel Briggs-Price (17735046)

    Published 2025
    Save to List
    Saved in:
  12. 172
    Neutrophils from HIV-infected individuals with high CD4 T-cell count have increased IL-10 activity and decreased glycolysis.

    Neutrophils from HIV-infected individuals with high CD4 T-cell count have increased IL-10 activity and decreased glycolysis. by Garett Dunsmore (11021169)

    Published 2021
    Save to List
    Saved in:
  13. 173
    Inactivation of <i>ICL1</i> bypasses the effects of <i>MLS1</i> inactivation.

    Inactivation of <i>ICL1</i> bypasses the effects of <i>MLS1</i> inactivation. by Cynthia Alsayyah (18452506)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 174
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 175
    Oral infection with YFV-Asibi cap0 leads to lower viral loads in the midguts largely diminishing dissemination to secondary tissues.

    Oral infection with YFV-Asibi cap0 leads to lower viral loads in the midguts largely diminishing dissemination to secondary tissues. by Anja vom Hemdt (19787189)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 176
    Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for BP() and NB() under equal sample sizes ().

    Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for BP() and NB() under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 177
    NbNBR1 decreases the ubiquitination level of total protein after TYLCCNV/TYLCCNB infection.

    NbNBR1 decreases the ubiquitination level of total protein after TYLCCNV/TYLCCNB infection. by Tingting Zhou (163678)

    Published 2021
    Save to List
    Saved in:
  18. 178
    Activation is greater for youth in the before prize condition (<i>n</i> = 226) vs. after prize condition (<i>n</i> = 220) during large win > small win trials in the MTwiNS sample (<i>n</i> = 446).

    Activation is greater for youth in the before prize condition (<i>n</i> = 226) vs. after prize condition (<i>n</i> = 220) during large win > small win trials in the MTwiNS sample (... by Melissa K. Peckins (12042132)

    Published 2022
    Save to List
    Saved in:
  19. 179
    MAP-map analysis of activity decreases within olfactory bulb and preoptic dopaminergic regions.

    MAP-map analysis of activity decreases within olfactory bulb and preoptic dopaminergic regions. by Jessica C. Nelson (10906236)

    Published 2023
    Save to List
    Saved in:
  20. 180
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: